PARP1 V762A polymorphism affects the prognosis of myelodysplastic syndromes
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PARP1 V762A polymorphism affects the prognosis of myelodysplastic syndromes
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HAEMATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-01-31
DOI
10.1111/ejh.13393
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
- (2019) Anna M. Paczulla et al. NATURE
- NQO1*2 polymorphism predicts overall survival in MDS patients
- (2018) Alena Moudra et al. BRITISH JOURNAL OF HAEMATOLOGY
- The poly(ADP-ribose) polymerase inhibitor olaparib induces up-regulation of death receptors in primary acute myeloid leukemia blasts by NF-κB activation
- (2018) Isabella Faraoni et al. CANCER LETTERS
- PARP-1 protects against colorectal tumor induction, but promotes inflammation-driven colorectal tumor progression
- (2018) Bastian Dörsam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New polymorphisms of Xeroderma Pigmentosum DNA repair genes in myelodysplastic syndrome
- (2017) Sabrina Pinheiro Santiago et al. LEUKEMIA RESEARCH
- Poly (ADP-ribose) polymerase 1 mRNA levels strongly correlate with the prognosis of myelodysplastic syndromes
- (2017) P Diamantopoulos et al. Blood Cancer Journal
- Downregulation of PARP1 transcription by promoter-associated E2F4-RBL2-HDAC1-BRM complex contributes to repression of pluripotency stem cell factors in human monocytes
- (2017) Ewelina Wiśnik et al. Scientific Reports
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents – A Potential Therapy for Cancer
- (2016) Nidal E. Muvarak et al. CANCER CELL
- A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia
- (2016) Keith W. Pratz et al. CLINICAL CANCER RESEARCH
- A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid Leukemia
- (2016) Ivana Gojo et al. CLINICAL CANCER RESEARCH
- PARP1 enhances lung adenocarcinoma metastasis by novel mechanisms independent of DNA repair
- (2016) E-B Choi et al. ONCOGENE
- High PARP-1 expression is associated with tumor invasion and poor prognosis in gastric cancer
- (2016) Ying Liu et al. Oncology Letters
- Association of XPD (Lys751Gln) and XRCC1 (Arg280His) gene polymorphisms in myelodysplastic syndrome
- (2015) Dolly Joshi et al. ANNALS OF HEMATOLOGY
- The PARP inhibitor Olaparib disrupts base excision repair of 5-aza-2′-deoxycytidine lesions
- (2014) Manuel Luis Orta et al. NUCLEIC ACIDS RESEARCH
- Association between the PARP1 Val762Ala Polymorphism and Cancer Risk: Evidence from 43 Studies
- (2014) Rui-Xi Hua et al. PLoS One
- PARP-1 Val762Ala Polymorphism and Risk of Cancer: A Meta-Analysis Based on 39 Case-Control Studies
- (2014) Qin Qin et al. PLoS One
- Cisplatin Resistance Associated with PARP Hyperactivation
- (2013) J. Michels et al. CANCER RESEARCH
- Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
- (2013) T Haferlach et al. LEUKEMIA
- Polymorphisms in genes of APE1, PARP1, and XRCC1: risk and prognosis of colorectal cancer in a Northeast Chinese population
- (2013) Ye Li et al. MEDICAL ONCOLOGY
- PARP-1 Regulates Metastatic Melanoma through Modulation of Vimentin-induced Malignant Transformation
- (2013) María Isabel Rodríguez et al. PLoS Genetics
- PARP-1: Friend or Foe of DNA Damage and Repair in Tumorigenesis?
- (2013) Amanda Swindall et al. Cancers
- Revised International Prognostic Scoring System for Myelodysplastic Syndromes
- (2012) P. L. Greenberg et al. BLOOD
- PARP-1 protein expression in glioblastoma multiforme
- (2012) A. Galia et al. EUROPEAN JOURNAL OF HISTOCHEMISTRY
- Selected Polymorphisms of Base Excision Repair Genes and Pancreatic Cancer Risk in Japanese
- (2012) Makoto Nakao et al. JOURNAL OF EPIDEMIOLOGY
- Synthetic Lethal Interactions between EGFR and PARP Inhibition in Human Triple Negative Breast Cancer Cells
- (2012) Somaira Nowsheen et al. PLoS One
- Association between PARP-1 V762A polymorphism and cancer susceptibility: a meta-analysis
- (2011) Hongping Yu et al. GENETIC EPIDEMIOLOGY
- PARP-1 Val762Ala polymorphism is associated with reduced risk of non-Hodgkin lymphoma in Korean males
- (2010) Xue Mei Jin et al. BMC Medical Genetics
- Novel Treatment Approaches for Triple-Negative Breast Cancer
- (2010) Melinda L. Telli et al. Clinical Breast Cancer
- Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson's disease onset
- (2009) Andreas Plaitakis et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms
- (2009) Masashi Sanada et al. NATURE
- RETRACTED ARTICLE: Poly(Adenosine Diphosphate-Ribose) Polymerase-1 Expression in Cutaneous Malignant Melanomas as a New Molecular Marker of Aggressive Tumor
- (2009) Béla Csete et al. PATHOLOGY & ONCOLOGY RESEARCH
- Parp1 Localizes within the Dnmt1 Promoter and Protects Its Unmethylated State by Its Enzymatic Activity
- (2009) Michele Zampieri et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now